ARCHIVES

What Should NCI Do When Center Directors Leave? Kimes Asks

This article is from The Cancer Letter archive.

Vol. 18 No. 30 | July 24, 1992

Download PDF Visit The Full Archive

Related Articles

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:

February 7, 1997

In Brief: President Proposes $1,994 Billion For NCI;

February 10, 1995

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013